Search Results
13 items found for " Laurette Geldenhuys"
Posts (4)
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz , M.D., has 50 years of experience
- 📰 GPCR Weekly News, October 2 to 8, 2023
research ‘Define your own success’: Duke leaders talk success, failure at symposium honoring Nobel Laureate
- 📰 GPCR Weekly News, October 9 to 15, 2023
formation in the social amoeba Dictyostelium discoideum evolved under low relatedness Industry News Nobel Laureates
Other Pages (9)
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Platform for Comprehensive Profiling of adhesion GPCR Signaling and Pharmacology-Enabling Drug Discovery Laurent , Canada (2) Department of Pharmacology-Physiology, Université de Sherbrooke, Québec, Canada" About Laurent Sabbagh "Laurent holds a Ph.D. in immunology from McGill University. Laurent is currently leading DTNA discovery group working on GPCRs in immuno-oncology to discover new Laurent Sabbagh on the web Domain Therapeutics Characterizing hADGRE5/CD97 Activation and Signaling:
- Ep 09 with Lauren Celano
GPCR Podcast << Back to podcast list Lauren Celano About this episode In this special Dr. GPCR podcast episode, we sat down to chat with Lauren Celano to talk about career options for Ph.D.’s Lauren has a science background and is passionate about helping talented scientists find their dream Lauren Celano on the web LinkedIn Propel Careers Email: Lauren@propelcareers.com Dr.
- Ep 49 with Dr. Sudha Shenoy
Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr.